Welcome to the Save Your Skin Foundation media flashback- your weekly guide to the melanoma landscape, and the activities of the Save Your Skin Foundation! We would like to start off this week with a little gratitude; here is our six month review and big thank you to all of our supporters, sponsors, and social media followers. We couldn’t do this work without you, and we love you! We are also very excited to announce our upcoming webinar, a post-ASCO review with Dr. Omid Hamid, Director of the Melanoma Center at the Angeles Clinic and Research Institute! More details, and where to register, can be found in the banner below. Lastly, if you are interested in the process of melanoma diagnosis, check out our new blog post “Diagnosis: Melanoma and Other Skin Cancers” here.
Here are some links we shared with you this week:
–This throwback to Market Wired’s coverage of our #NotJustSkinCancer campaign!
–These details on the combination of Tafinlar and Mekinist being added to the BCCA “Formulary”
–This article on Doctors of BC about the Canadian Cancer Society’s new sun safety guidelines
–This piece and video on Mommy Talk Show about sun safety for children
-The Melanoma Just Got Personal web page, which has personal melanoma stories, information, and other resources
–This Global News piece on immunotherapy
–This Canadian Mining Journal article about the importances of sun safety in order to protect against skin cancer and increase morale
–This article in Business Wire covering Incyte Corporation’s announcement that the first patient in the ECHO-301 study- the combination of Incyte’s epacadostat and Keytruda as a treatment for patients with advanced or metastatic melanoma- has been treated
–These National Cancer Institute sun safety guidelines
–The Saskatchewan Cancer Agency’s “Formulary,” which now lists Tafinlar as approved for some cases of advanced unresectable or metastatic melanoma
Thank you for reading, stay sun safe out there!